Profile | GDS4284 / 211769_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 5201.72 | 93 |
GSM687648 | Patient 402 control | 3491.77 | 90 |
GSM687653 | Patient 403 control | 4172.57 | 92 |
GSM687658 | Patient 404 control | 5237.47 | 94 |
GSM687663 | Patient 411 control | 5884.97 | 95 |
GSM687668 | Patient 422 control | 4978.65 | 93 |
GSM687673 | Patient 424 control | 6122.92 | 95 |
GSM687678 | Patient 425 control | 6260.38 | 95 |
GSM687683 | Patient 427 control | 5925.81 | 95 |
GSM687688 | Patient 428 control | 6713.58 | 95 |
GSM687695 | Patient 441 control | 8731.12 | 96 |
GSM687699 | Patient 443 control | 3421.63 | 90 |
GSM687704 | Patient 444 control | 6206.7 | 95 |
GSM687707 | Patient 448 control | 7041.32 | 95 |
GSM687712 | Patient 449 control | 6112.77 | 95 |
GSM687719 | Patient 450 control | 6347.83 | 95 |
GSM687724 | Patient 451 control | 5736.18 | 94 |
GSM687728 | Patient 452 control | 8583.64 | 96 |
GSM687646 | Patient 401 treated 24h | 4329.13 | 92 |
GSM687649 | Patient 402 treated 24h | 4254.49 | 92 |
GSM687665 | Patient 411 treated 24h | 4826.93 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 5332.42 | 94 |
GSM687667 | Patient 411 treated 4 weeks | 4554.07 | 93 |
GSM687670 | Patient 422 treated 24h | 5091.93 | 94 |
GSM687671 | Patient 422 treated 4 weeks | 5009.86 | 93 |
GSM687654 | Patient 403 treated 24h | 4687.93 | 93 |
GSM687675 | Patient 424 treated 24h | 5971.95 | 95 |
GSM687685 | Patient 427 treated 24h | 6198.55 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 5142.48 | 93 |
GSM687677 | Patient 424 treated 4 weeks | 5870.26 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 5643.94 | 94 |
GSM687692 | Patient 428 treated 4h | 5313.83 | 94 |
GSM687716 | Patient 449 treated 4h | 5573.75 | 94 |
GSM687722 | Patient 450 treated 4h | 4907.99 | 93 |
GSM687680 | Patient 425 treated 24h | 7059.02 | 96 |
GSM687690 | Patient 428 treated 24h | 5006.96 | 93 |
GSM687700 | Patient 443 treated 24h | 6024.24 | 95 |
GSM687705 | Patient 444 treated 24h | 5501.54 | 94 |
GSM687714 | Patient 449 treated 24h | 5554.63 | 94 |
GSM687721 | Patient 450 treated 24h | 8059.26 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 5920.35 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 5391.2 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 4389.32 | 92 |
GSM687718 | Patient 449 treated 4 weeks | 5331.37 | 94 |
GSM687723 | Patient 450 treated 4 weeks | 5706.56 | 94 |
GSM687661 | Patient 404 treated 4h | 4820.43 | 93 |
GSM687710 | Patient 448 treated 4h | 7263.02 | 96 |
GSM687726 | Patient 451 treated 4h | 8218 | 96 |
GSM687730 | Patient 452 treated 4h | 871.67 | 71 |
GSM687660 | Patient 404 treated 24h | 6203.71 | 95 |
GSM687697 | Patient 441 treated 24h | 11024.2 | 97 |
GSM687709 | Patient 448 treated 24h | 6122.79 | 95 |
GSM687725 | Patient 451 treated 24h | 6796.56 | 95 |
GSM687729 | Patient 452 treated 24h | 11806.5 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 8247.5 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 8673.63 | 97 |